Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 May 19;3(2):ofw100. doi: 10.1093/ofid/ofw100

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author 2016. Published by Oxford University Press on behalf of the Infectious Diseases Society of America.

This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.

PMC Copyright notice

Figure 5. — The association between immunoglobulin G (IgG) epitope specificity and glycoprotein (gp)140 enzyme-linked immunosorbent assay (ELISA) titer and/or tier 1A neutralizing antibody (NAb) responses in human immunodeficiency virus (HIV)-infected subjects treated with antiretroviral therapy (ART) at 4 weeks post-analytic treatment interruption (ATI) and 20 weeks post-ATI. Average mean fluorescent intensity (MFI) of IgG binding to third hypervariable loop (V3), CC loop, and cytoplasmic tail peptides is plotted against (A) gp140 ELISA titer at 4 weeks post-ATI, (B) gp140 ELISA titer at 20 weeks post-ATI, and (C) tier 1A NAb titer at 20 weeks post-ATI. Abbreviation: NS, not significant.